Servier to Take Day One Biopharmaceuticals Private

Servier Detroit Inc., a direct wholly owned subsidiary of Servier Pharmaceuticals LLC, filed Amendment No. 2 to its Schedule TO under Rule 13e-3 for a going-private tender offer for Day One Biopharmaceuticals, Inc. The filing relates to an offer by the Servier Parties to purchase all issued and outstanding shares of Day One common stock.

The Schedule TO amendment was filed on top of the original tender offer statement submitted March 26, 2026, and it updates Item 11 Additional Information, including an amended and restated Antitrust Compliance section. The filing references the Offer to Purchase and related tender documents as exhibits.